)
PMV Pharmaceuticals (PMVP) investor relations material
PMV Pharmaceuticals Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved positive Phase 2 interim data for rezatapopt in the PYNNACLE trial for TP53 Y220C-mutated cancers.
Enrollment remains on track for the pivotal Phase 2 portion, with NDA submission planned for Q1 2027.
Rezatapopt received Orphan Drug Designation and Fast Track status from the FDA for TP53 Y220C positive ovarian cancer.
Published first-in-human data in NEJM showing selective p53 reactivation and antitumor activity.
Financial highlights
Cash, cash equivalents, and marketable securities totaled $112.9 million as of December 31, 2025, down from $183.3 million at year-end 2024.
Net loss for 2025 was $77.7 million, compared to $58.7 million in 2024.
Net cash used in operations was $73.6 million for 2025, up from $51.3 million in 2024.
R&D expenses rose to $69.9 million in 2025, primarily due to advancing rezatapopt clinical development.
G&A expenses decreased to $16.3 million in 2025, reflecting lower facility and personnel costs after relocation and staff reductions.
Outlook and guidance
Cash runway expected to last through the end of Q2 2027.
NDA submission for rezatapopt in platinum-resistant/refractory ovarian cancer planned for Q1 2027.
Next PMV Pharmaceuticals earnings date
Next PMV Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)